Latest On Aesthetic Medical International Holdings Group Limited (AIH):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-17 13:04 EST | News | Aesthetic Medical International Holdings Group Limited (AIH) Q4 2022 Earnings Call Transcript | N/A |  |
| 2023-05-17 13:03 EST | News | Aesthetic Medical International GAAP EPS of $0.0006, revenue of $21.7M | N/A | |
| 2023-04-21 16:56 EST | News | Aesthetic Medical International Holdings Group Limited (AIH) Q1 2023 Earnings Call Transcript | N/A | |
| 2022-12-07 06:46 EST | News | Aesthetic Medical gets Nasdaq notice on minimum shareholders' equity rule | N/A | |
| 2022-11-29 19:24 EST | News | Aesthetic Medical International GAAP EPS of -RMB0.60, revenue of RMB167.4M | N/A | |
| 2022-11-29 19:23 EST | News | Aesthetic Medical International Holdings Group Limited (AIH) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-08-17 12:47 EST | News | Aesthetic Medical International GAAP EPS of -$0.01, revenue of $50.6M | N/A | |
| 2022-08-17 12:47 EST | News | Aesthetic Medical International Holdings Group Limited (AIH) CEO Pengwu Zhou on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-07-20 17:34 EST | News | Aesthetic Medical International and investors enter share purchase and other agreements | N/A | |
| 2022-06-29 10:23 EST | News | Aesthetic Medical International GAAP EPS of -$0.01, revenue of $25.35M | N/A | |
| 2022-06-06 15:03 EST | News | Aesthetic Medical International received Nasdaq non-compliance notice over minimum stockholders’ equity requirement | N/A | |
| 2022-05-14 09:14 EST | News | Aesthetic Medical International GAAP EPS of -$1.40, revenue of $645.6M | N/A | |
| 2021-12-06 09:37 EST | News | Aesthetic Medical International updates on newly-acquired non-surgical business in Guangzhou | N/A | |
| 2021-11-16 14:26 EST | News | Aesthetic Medical International reports FQ2 results | N/A | |
| 2021-11-16 14:25 EST | News | Aesthetic Medical International Holdings Group Limited (AIH) CEO Dr. Pengwu Zhou on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-01 06:11 EST | News | Aesthetic Medical announces restructuring plans to optimize business operations | N/A | |
| 2021-09-30 07:23 EST | News | Warning: AIH has been downgraded to Very Bearish | N/A | |
| 2021-09-22 18:39 EST | News | Warning: AIH has been downgraded to Very Bearish. | N/A | |
| 2021-07-22 16:52 EST | News | Aesthetic Medical International Holdings Group Limited (AIH) CEO Pengwu Zhou on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-04-20 18:12 EST | News | Aesthetic Medical International's (AIH) CEO Pengwu Zhou on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-19 00:53 EST | Analyst Rating | The Analyst Target Price has decreased from $8 to $7.99. | Neutral | |
| 2021-03-18 11:28 EST | Analyst Rating | The Analyst Target Price has decreased from $8.01 to $8. | Neutral | |
| 2021-03-17 15:36 EST | Analyst Rating | The Analyst Target Price has increased from $7.99 to $8.01. | Buy | |
| 2021-03-17 00:09 EST | Analyst Rating | The Analyst Target Price has decreased from $8.01 to $7.99. | Neutral | |
| 2021-03-13 06:08 EST | Analyst Rating | The Analyst Target Price has increased from $8 to $8.01. | Buy | |
| 2021-03-12 14:02 EST | Analyst Rating | The Analyst Target Price has increased from $7.95 to $8. | Neutral | |
| 2021-03-11 02:31 EST | Analyst Rating | The Analyst Target Price has increased from $7.92 to $7.95. | Buy | |
| 2021-03-09 22:45 EST | Analyst Rating | The Analyst Target Price has decreased from $7.95 to $7.92. | Neutral | |
| 2021-03-08 22:28 EST | Analyst Rating | The Analyst Target Price has decreased from $8 to $7.95. | Neutral | |
| 2021-03-05 22:41 EST | Analyst Rating | The Analyst Target Price has increased from $7.99 to $8. | Buy | |
| 2021-03-05 10:11 EST | Analyst Rating | The Analyst Target Price has increased from $7.98 to $7.99. | Buy | |
| 2021-03-04 02:36 EST | Analyst Rating | The Analyst Target Price has increased from $7.97 to $7.98. | Buy | |
| 2021-03-01 22:27 EST | Analyst Rating | The Analyst Target Price has decreased from $7.99 to $7.97. | Neutral | |
| 2021-02-26 13:52 EST | Analyst Rating | The Analyst Target Price has increased from $7.98 to $7.99. | Buy | |
| 2021-02-25 00:18 EST | Analyst Rating | The Analyst Target Price has increased from $7.97 to $7.98. | Neutral | |
| 2021-02-23 22:48 EST | Analyst Rating | The Analyst Target Price has decreased from $7.98 to $7.97. | Neutral | |
| 2021-02-23 02:29 EST | Analyst Rating | The Analyst Target Price has increased from $7.96 to $7.98. | Neutral | |
| 2021-02-20 02:22 EST | Analyst Rating | The Analyst Target Price has decreased from $7.99 to $7.96. | Neutral | |
| 2021-02-19 13:59 EST | Analyst Rating | The Analyst Target Price has decreased from $8 to $7.99. | Neutral | |
| 2021-02-11 22:37 EST | Analyst Rating | The Analyst Target Price has decreased from $8.02 to $8. | Neutral | |
| 2021-02-10 22:29 EST | Analyst Rating | The Analyst Target Price has increased from $8.01 to $8.02. | Buy | |
| 2021-02-10 10:03 EST | Analyst Rating | The Analyst Target Price has increased from $7.97 to $8.01. | Buy | |
| 2021-02-05 22:26 EST | Analyst Rating | The Analyst Target Price has decreased from $8.03 to $7.97. | Neutral | |
| 2021-02-04 10:27 EST | Analyst Rating | The Analyst Target Price has increased from $8.02 to $8.03. | Buy | |
| 2021-02-03 10:12 EST | Analyst Rating | The Analyst Target Price has decreased from $8.07 to $8.02. | Neutral | |
| 2021-02-01 06:11 EST | Analyst Rating | The Analyst Target Price has increased from $8.04 to $8.07. | Buy | |
| 2021-01-29 22:27 EST | Analyst Rating | The Analyst Target Price has increased from $7.96 to $8.04. | Buy | |
| 2021-01-28 22:22 EST | Analyst Rating | The Analyst Target Price has decreased from $7.99 to $7.96. | Neutral | |
| 2021-01-28 10:01 EST | Analyst Rating | The Analyst Target Price has increased from $7.97 to $7.99. | Buy | |
| 2021-01-26 10:04 EST | Analyst Rating | The Analyst Target Price has decreased from $8 to $7.97. | Neutral | |
About Aesthetic Medical International Holdings Group Limited (AIH):
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 25 treatment centers in China, Hong Kong, and Singapore. The company was founded in 1997 and is headquartered in Shenzhen, China.
General
- Name Aesthetic Medical International Holdings Group Limited
- Symbol AIH
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Care Facilities
- Full Time Employees 1,550
- Fiscal Year EndDecember
- IPO Date2019-10-25
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Providers & Services
- Gic SubIndustryHealth Care Services
- Web URLhttp://ir.aihgroup.net
View More
Valuation
- Trailing PE 8.68
- Forward PE 18.35
- Price/Sales (Trailing 12 Mt.) 1.44
- Price/Book (Most Recent Quarter) 2.48
- Enterprise Value Revenue 0.33
- Enterprise Value EBITDA 2.85
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate $0.49
- Profit Margin -28%
- Return on Assets -12%
- Return on Equity -90%
- Revenue Per Share $0
- Gross Profit 593.1 million
- Quarterly Earnings Growth 18.3%
View More
Highlights
- Market Capitalization 176.86 million
- Analyst Target Price $7.99
View More
Share Statistics
- Shares Outstanding 23.61 million
- Shares Float 2.6 million
- % Held by Insiders <1%
- % Held by Institutions 4.24%
- Shares Short 21671
- Shares Short Prior Month 21781
- Short Ratio 0.1
View More
Technicals
- 52 Week High $9.78
- 52 Week Low $3.81
- 50 Day Moving Average 6.84
- 200 Day Moving Average 5.5
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Aesthetic Medical International Holdings Group Limited (AIH) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Aesthetic Medical International Holdings Group Limited (AIH) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-30 | $281.32 million | $0.02 | $0.26 | -93.12% |
| 2020-06-30 | 2020-09-25 | $N/A | -$0.06 | -$0.08 | 20.13% |
| 2020-03-31 | 2020-04-24 | $N/A | $0.01 | $0.17 | -93.18% |
| 2019-12-31 | 2019-12-31 | $N/A | $0.30 | $1.20 | -75% |
| 2019-09-30 | 2019-11-26 | $237.89 million | $0.15 | $0.15 | -0.67% |
Aesthetic Medical International Holdings Group Limited (AIH) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Aesthetic Medical International Holdings Group Limited (AIH) Chart:
Aesthetic Medical International Holdings Group Limited (AIH) News:
Below you will find a list of latest news for Aesthetic Medical International Holdings Group Limited (AIH) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Aesthetic Medical International Holdings Group Limited (AIH) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Aesthetic Medical International Holdings Group Limited (AIH) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1757143/000110465920077047/0001104659-20-077047-index.htm |
| 2019-02-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1757143/000000000019001552/0000000000-19-001552-index.htm |
| 2019-06-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1757143/000000000019010172/0000000000-19-010172-index.htm |
| 2019-07-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1757143/000000000019010848/0000000000-19-010848-index.htm |
| 2019-09-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1757143/000000000019013608/0000000000-19-013608-index.htm |
| 2019-10-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1757143/000000000019014363/0000000000-19-014363-index.htm |
| 2019-05-30 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1757143/000091205719000233/0000912057-19-000233-index.htm |
| 2019-07-01 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1757143/000091205719000285/0000912057-19-000285-index.htm |
| 2018-12-07 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1757143/000091205719000339/0000912057-19-000339-index.htm |
| 2019-09-03 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1757143/000091205719000367/0000912057-19-000367-index.htm |
| 2019-09-30 | F-1 | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1757143/000104746919005529/0001047469-19-005529-index.htm |
| 2019-10-15 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1757143/000104746919005741/0001047469-19-005741-index.htm |
| 2019-10-23 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1757143/000104746919005846/0001047469-19-005846-index.htm |
| 2019-10-25 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1757143/000104746919005912/0001047469-19-005912-index.htm |
| 2019-09-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1757143/000110465919052069/0001104659-19-052069-index.htm |
| 2019-10-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1757143/000110465919054071/0001104659-19-054071-index.htm |
| 2019-10-15 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1757143/000110465919054076/0001104659-19-054076-index.htm |
| 2019-10-21 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1757143/000110465919055218/0001104659-19-055218-index.htm |
| 2019-10-21 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1757143/000110465919055219/0001104659-19-055219-index.htm |
| 2019-11-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1757143/000110465919067269/0001104659-19-067269-index.htm |
| 2020-03-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1757143/000110465920028881/0001104659-20-028881-index.htm |
| 2020-03-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1757143/000110465920028886/0001104659-20-028886-index.htm |
| 2020-03-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1757143/000110465920029935/0001104659-20-029935-index.htm |
| 2020-04-24 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1757143/000110465920050594/0001104659-20-050594-index.htm |
| 2020-04-24 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1757143/000110465920051042/0001104659-20-051042-index.htm |
| 2020-04-30 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1757143/000110465920053940/0001104659-20-053940-index.htm |
| 2020-06-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1757143/000110465920077047/0001104659-20-077047-index.htm |
| 2020-09-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1757143/000110465920102803/0001104659-20-102803-index.htm |
| 2020-09-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1757143/000110465920105111/0001104659-20-105111-index.htm |
| 2020-09-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1757143/000110465920108495/0001104659-20-108495-index.htm |
| 2020-10-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1757143/000110465920114247/0001104659-20-114247-index.htm |
| 2020-04-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1757143/000114036120009327/0001140361-20-009327-index.htm |
| 2020-09-22 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1757143/000114036120021125/0001140361-20-021125-index.htm |
| 2019-10-15 | F-6 | Registration of American Depository Receipt shares, not immediately effective | https://www.sec.gov/Archives/edgar/data/1757143/000120864619000090/0001208646-19-000090-index.htm |
| 2019-10-24 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1757143/000135445719000544/0001354457-19-000544-index.htm |
| 2018-12-07 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1757143/000141057818000592/0001410578-18-000592-index.htm |
| 2019-05-30 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1757143/000141057819000275/0001410578-19-000275-index.htm |
| 2019-07-01 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1757143/000141057819000502/0001410578-19-000502-index.htm |
| 2019-08-09 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1757143/000141057819000736/0001410578-19-000736-index.htm |
| 2019-09-03 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1757143/000141057819000997/0001410578-19-000997-index.htm |
| 2019-10-24 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1757143/999999999519002386/9999999995-19-002386-index.htm |
| 2019-10-24 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1757143/999999999519002388/9999999995-19-002388-index.htm |